CA2295429A1 - Treatment or prevention of diarrhea - Google Patents

Treatment or prevention of diarrhea Download PDF

Info

Publication number
CA2295429A1
CA2295429A1 CA002295429A CA2295429A CA2295429A1 CA 2295429 A1 CA2295429 A1 CA 2295429A1 CA 002295429 A CA002295429 A CA 002295429A CA 2295429 A CA2295429 A CA 2295429A CA 2295429 A1 CA2295429 A1 CA 2295429A1
Authority
CA
Canada
Prior art keywords
irinotecan
diarrhea
carbon
patient
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002295429A
Other languages
English (en)
French (fr)
Inventor
Michael Michael
Malcolm J. Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002295429A priority Critical patent/CA2295429A1/en
Priority to AU23356/01A priority patent/AU2335601A/en
Priority to PCT/CA2000/001544 priority patent/WO2001049299A2/en
Priority to PE2000001409A priority patent/PE20010990A1/es
Priority to ARP010100029A priority patent/AR026791A1/es
Publication of CA2295429A1 publication Critical patent/CA2295429A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002295429A 2000-01-06 2000-01-06 Treatment or prevention of diarrhea Abandoned CA2295429A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA002295429A CA2295429A1 (en) 2000-01-06 2000-01-06 Treatment or prevention of diarrhea
AU23356/01A AU2335601A (en) 2000-01-06 2000-12-21 Treatment or prevention of diarrhea
PCT/CA2000/001544 WO2001049299A2 (en) 2000-01-06 2000-12-21 Prevention of ironotecan induced diarrhea with activated carbon
PE2000001409A PE20010990A1 (es) 2000-01-06 2000-12-28 Un kit que comprende como un primer componente irinotecano o una composicion que comprende irinotecano y como un segundo componente una o varias dosis de carbon
ARP010100029A AR026791A1 (es) 2000-01-06 2001-01-04 Metdo para prevenir o aliviar la diarrea causada por el agente quimioterapeutico irinotecano, administrando carbon al paciente.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002295429A CA2295429A1 (en) 2000-01-06 2000-01-06 Treatment or prevention of diarrhea

Publications (1)

Publication Number Publication Date
CA2295429A1 true CA2295429A1 (en) 2001-07-06

Family

ID=4165060

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002295429A Abandoned CA2295429A1 (en) 2000-01-06 2000-01-06 Treatment or prevention of diarrhea

Country Status (5)

Country Link
AR (1) AR026791A1 (es)
AU (1) AU2335601A (es)
CA (1) CA2295429A1 (es)
PE (1) PE20010990A1 (es)
WO (1) WO2001049299A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2454648A1 (en) * 2001-07-23 2003-02-20 Epidauros Biotechnologie Ag Irinotecan for treatment of cancer
WO2004103371A1 (en) * 2003-05-21 2004-12-02 Pharmacia & Upjohn Company Llc Use of cftr inhibitors for the treatment of chemotherapy-induced diarrhea

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999065493A1 (en) * 1998-06-18 1999-12-23 The George Washington University Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects
DE69901506T2 (de) * 1998-08-05 2002-11-28 Aventis Pharma Sa Verwendung von natriumchlorid zur verminderung der gastrointestinalen toxizität von camptotecinderivaten.
WO2001052828A2 (en) * 2000-01-18 2001-07-26 University Of Massachusetts Glutamine prevention of delayed-onset irinotecan-induced diarrhea

Also Published As

Publication number Publication date
WO2001049299A2 (en) 2001-07-12
PE20010990A1 (es) 2001-09-22
WO2001049299A3 (en) 2002-02-21
AU2335601A (en) 2001-07-16
AR026791A1 (es) 2003-02-26

Similar Documents

Publication Publication Date Title
RU2429838C2 (ru) Комбинированная химиотерапия
AU2006315512B2 (en) Administration of an mTOR inhibitor to treat patients with cancer
CA2342981A1 (en) Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin
US7834056B2 (en) Pharmaceutical composition for gout
MXPA02011610A (es) Combinacion de sustancia activa que contiene un opioide que tiene una estructura tipo fentanilo y cetamina.
CA2703044C (en) Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy
JP5416327B2 (ja) タキサンにより惹起される神経毒性を予防又は軽減するための薬剤
WO1992003135A1 (en) Pharmaceutical compositions containing 5-difluoromethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl] benzimidazole and an anti-helicobacter agent for the treatment of gastrointestinal disorders
CA2295429A1 (en) Treatment or prevention of diarrhea
US3852453A (en) Method of enhancing vincamine compositions
US6562834B2 (en) Combination comprising camptothecin and a stilbene derivative for the treatment of cancer
CN115135326B (zh) 作为c-Met激酶抑制剂的化合物的联用药物组合物及其用途
CA2100777C (en) Pharmaceutical composition containing granisetron and dexamethasone
AU2002216029A1 (en) A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
JP4695326B2 (ja) 鼻炎用医薬組成物
TWI858861B (zh) Bet抑制劑及parp抑制劑於治療胰臟癌之用途
DE3874982T2 (de) Antipsychotische zusammensetzungen mit dioxopiperidin-derivaten.
US8168662B1 (en) Use of picoplatin to treat colorectal cancer
RU2284818C2 (ru) Комбинированная химиотерапия
EP1485090B1 (en) Combinations comprising an epothilone derivative and an imidazotetrazinone
US20060009475A1 (en) Quinazolinone compounds in combined modalities for improved cancer treatment
Douglass et al. Alternating administration of Adriamycin (NSC‐123127) and vincristine (NSC‐67574)‐actinomycin (NSC‐3053) in advanced sarcomas
WO2001052828A2 (en) Glutamine prevention of delayed-onset irinotecan-induced diarrhea
CN115444938A (zh) cGAS抑制剂与化疗药物联合在制备治疗肺癌药物中的用途
JP2009235093A (ja) 鼻炎用医薬組成物

Legal Events

Date Code Title Description
FZDE Dead